ArticlePloS one2025

A novel oncolytic vaccinia virus with multiple gene modifications involved in viral replication and maturation increases safety for intravenous administration while maintaining proliferative potential in cancer cells.

Go Okita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.